mecamylamine has been researched along with Carcinoma, Hepatocellular in 1 studies
Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.
Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nie, H | 1 |
| Cao, Q | 1 |
| Zhu, L | 1 |
| Gong, Y | 1 |
| Gu, J | 1 |
| He, Z | 1 |
1 other study available for mecamylamine and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Acetylcholine acts on androgen receptor to promote the migration and invasion but inhibit the apoptosis of human hepatocarcinoma.
Topics: Acetylcholine; Androgen Antagonists; Androgens; Anilides; Apoptosis; Carcinoma, Hepatocellular; Cell | 2013 |